CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 28 enrolled
Drug / intervention
Veregen only +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02622568
NCT02622568Phase 4Completed
CompareCT.gov

Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

University of Texas Southwestern Medical Center·interventional·Posted Dec 4, 2015·Updated Sep 8, 2017

In Brief

A Phase 4 clinical trial evaluating Veregen only and Cryotherapy and Veregen for Verruca, Warts. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate topical treatment with Veregen™ 15% ointment as a single therapeutic agent and compare it to combination therapy with Veregen ™ 15% ointment and a single destructive treatment by cryotherapy for non-facial verruca vulgaris in the pediatric population. This novel treatment modality may be useful in the pediatric dermatology community offering a less invasive, painless option for treatment of non-facial verruca vulgaris.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVerruca, Warts
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 4, 2015
Enrollment StartJul 1, 2015
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.6 years ago

Interventions

Veregen onlydrug

Topical application of Veregen 15% ointment on affected areas twice daily

Cryotherapy and Veregenprocedure

Cryotherapy followed by topical application of Veregen 15% ointment on affected areas twice daily